Prior conversion re-papered to end litigation, with economics essentially unchanged

The filing resolves a legal overhang, not an economic one. The March 11 conversion had already delivered the Investors 1,601,505 common shares at a $32 conversion price; this agreement reverses the questioned corporate filings, recreates the preferred stock briefly as Series B, and immediately reconverts it into the same number of common shares (Item 1.01; Item 3.03). The stockholder complaint is voluntarily dismissed, removing uncertainty around the validity of those shares, but the company does not concede wrongdoing or settle through a disclosed cash payment.

The main benefit is certainty and avoided cost. Compared with the standing risk that the March filings or Subject Shares could remain contested, Sonida now has a clean sequence of correction filings, a replacement Series B designation, reconversion, and dismissal. It also pays no additional cash under the August agreement, unlike the approximately $5.8 million payment made in March (Item 1.01; Item 3.03).

The capital-structure burden remains intact. Investors still received the same 1.60 million common shares, and the 1.03 million $40 warrants remain outstanding through November 3, 2027, so this filing does not reduce dilution or improve the underlying ownership economics (Item 1.01). With no conventional earnings or transaction-consideration consensus applicable, the cleanest benchmark is the prior March outcome: August removes legal uncertainty and avoids another cash payment, but leaves the substantive dilution unchanged. The net read is therefore mixed rather than a fundamental positive.